These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6684447)

  • 1. [Clinical trial of febuprol, a new substance with choleretic activity. Study of efficacy and tolerability].
    Ritter U; Kyrein HJ
    Arzneimittelforschung; 1983; 33(6):891-7. PubMed ID: 6684447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lithogenicity and bile acid pattern in choleretic administration (3-n-butoxy-1-phenoxy-propanol: febuprol) in patients with functional right upper quadrant pain].
    Swobodnik W; Wechsler JG; Klüppelberg U; Janowitz P; Hutt V; Ditschuneit H
    Z Gastroenterol; 1987 Nov; 25(11):715-20. PubMed ID: 3324520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On pharacokinetics and metabolism of the choleretic agent febuprol (author's transl)].
    Rehm K; hempel K; Maurer-Schultze B; Schlemmer W
    Arzneimittelforschung; 1976; 26(5):813-20. PubMed ID: 989353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid composition and cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones under choleretic treatment with Febuprol.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    Z Gastroenterol; 1988 May; 26(5):275-8. PubMed ID: 3407249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the spasmolytic action of 3-butoxy-1-phenoxy-propanol-(2) (febuprol) on the biliary tract (author's transl)].
    Eisenburger R
    Arzneimittelforschung; 1977 Jul; 27(7):1429-33. PubMed ID: 578468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on the choleretic agent Febuprol (author's transl)].
    Scholing WE; Weinert W
    MMW Munch Med Wochenschr; 1978 Feb; 120(5):143-6. PubMed ID: 342924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic evaluation of 3-butoxy-l-phenoxy-propanol-(2), a new substance with choleretic activity].
    Hofrichter G; Hampel H; Liehn HD; Ludwig E
    Arzneimittelforschung; 1974 Jan; 24(1):111-8. PubMed ID: 4406096
    [No Abstract]   [Full Text] [Related]  

  • 8. [Investigation of the choleretic action of febuprol on healthy test subjects (author's transl)].
    Wolf C; Ritter U; Zschocke R; Weinert W
    MMW Munch Med Wochenschr; 1976 Oct; 118(40):1285-8. PubMed ID: 824554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effect of choleretic drug urocholesan in patients with chronic cholecystitis].
    Nemialkovskiĭ IB
    Vrach Delo; 1976 Dec; (12):76-8. PubMed ID: 1014594
    [No Abstract]   [Full Text] [Related]  

  • 10. [1-Phenyl-propanol as a choleretic].
    LANGECKER H; HARWART A; JUNKMANN K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1955; 225(4):303-8. PubMed ID: 13253659
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with a new synthetic choleretic 1-phenylpropanole].
    VALLECORSI G
    Minerva Med; 1956 Nov; 47(92):1617-9. PubMed ID: 13387319
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of urolesan and phenicarbaran in the combined treatment of chronic cholecystitis].
    Neĭko EM; Skrobach NV
    Vrach Delo; 1985 Jul; (7):13-6. PubMed ID: 4049815
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the choleretic action of 1-phenylpropanol].
    BRUGEL H; DOCKER O; MERTZ DP
    Dtsch Med Wochenschr; 1956 Oct; 81(42):1679-81. PubMed ID: 13375269
    [No Abstract]   [Full Text] [Related]  

  • 14. [Disorder in mechanisms of bile formation and methods of their correction].
    Iakovenko EP; Grigor'ev PIa; Agafonova NA; Iakovenko AV; Prianishnikova AS
    Eksp Klin Gastroenterol; 2003; (6):32-9. PubMed ID: 15065526
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research with experimental animals on the mechanism of action of the new choleretic, 3-ethyl-4-oxo-5-piperidino-delta 2, alpha-thiazolidine-acetic acid ethyl ester (Piprozolin)].
    Koss FW; Vollmer KO; Herrmann M
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):333-46. PubMed ID: 5074733
    [No Abstract]   [Full Text] [Related]  

  • 16. [RELATION BETWEEN CHOLERETIC ACTION AND SPASMOLYTIC ACTION IN RATS].
    CARMINATI GM
    Arch Int Pharmacodyn Ther; 1965 Feb; 153():312-22. PubMed ID: 14297370
    [No Abstract]   [Full Text] [Related]  

  • 17. Acemoquinazone, a new choleretic agent.
    Setnikar I
    Br J Pharmacol; 1968 Nov; 34(3):678P-679P. PubMed ID: 5726806
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-experimental study on a new substance with choleretic action (1-phenyl-1-hydroxy-n-pentane) associated with a spasmolytic having double atropine- and papaverine-like action in patients with hepatobiliary diseases].
    VANCINI B
    Minerva Med; 1962 May; 53():1478-86. PubMed ID: 13924674
    [No Abstract]   [Full Text] [Related]  

  • 19. [Roentgenologic evaluation of the choleretic effect of sorbite].
    Kitaev VV
    Ter Arkh; 1967 Aug; 39(8):40-3. PubMed ID: 5615300
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications and contraindications of choleretic therapy].
    Grossi F
    Clin Ter; 1974; 70(2):108-9. PubMed ID: 4409826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.